NCT05136950

Brief Summary

To compare the incidence of glaucoma-related adverse events of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
228

participants targeted

Target at P75+ for not_applicable

Timeline
88mo left

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Dec 2021Jul 2033

First Submitted

Initial submission to the registry

November 1, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

December 14, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2033

Expected
Last Updated

January 11, 2022

Status Verified

January 1, 2022

Enrollment Period

1.6 years

First QC Date

November 1, 2021

Last Update Submit

January 6, 2022

Conditions

Keywords

Pediatric aphakiaSecondary Intraocular Lens ImplantationGlaucoma-related Adverse EventsIn-the-bag IOL implantationSulcus IOL fixation

Outcome Measures

Primary Outcomes (1)

  • Incidence of glaucoma-related adverse events

    The assessment of glaucoma-related adverse events is performed at one year after surgery

    One year after surgery

Secondary Outcomes (6)

  • Incidence of glaucoma-related adverse events

    Six months,three years, five years, ten years after surgery

  • Visual acuity

    Six months,one year, three years, five years, ten years after surgery

  • Ocular refractive power

    Six months,one year,three years, five years, ten years after surgery

  • Intraocular lens decentration

    Six months,one year, three years, five years, ten years after surgery

  • Intraocular lens tilt

    Six months,one year, three years, five years, ten years after surgery

  • +1 more secondary outcomes

Study Arms (2)

Secondary in-the-bag IOL fixation group

EXPERIMENTAL

In-the-bag IOL fixation is the experimental arm

Procedure: Secondary in-the-bag IOL fixation

Secondary ciliary sulcus IOL fixation group

ACTIVE COMPARATOR

Ciliary sulcus IOL fixation is the control arm

Procedure: Secondary ciliary sulcus IOL fixation

Interventions

The experimental group with secondary IOL fixated in the capsular bag

Secondary in-the-bag IOL fixation group

The control group with secondary IOL fixated in the ciliary sulcus

Secondary ciliary sulcus IOL fixation group

Eligibility Criteria

Age18 Months - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 18 months and 14 years
  • Had a primary diagnosis of congenital cataract.
  • Underwent cataract extraction between the ages of 2 and 24 months

You may not qualify if:

  • Primary IOL implantation
  • Pre-existing ocular disease which might affect the location and outcome of secondary IOL implantation (including and not restricted to microphthalmia, microcornea, microcornea, corneal opacity, pseudopterygium, iris anomaly, glaucoma diagnosed before cataract extraction, uveitis, persistent fetal vasculature or trauma)
  • Suture fixation for secondary IOL implantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China, 510060

Guangzhou, 510060, China

RECRUITING

Related Publications (7)

  • Liu Z, Lin H, Jin G, Tan X, Qu B, Jin L, Chen X, Wang W, Han X, Xu J, Ying G, Han Y, He M, Congdon N, Chen W, Luo L, Liu Y. In-the-Bag Versus Ciliary Sulcus Secondary Intraocular Lens Implantation for Pediatric Aphakia: A Prospective Comparative Study. Am J Ophthalmol. 2022 Apr;236:183-192. doi: 10.1016/j.ajo.2021.10.006. Epub 2021 Oct 13.

  • Wood KS, Tadros D, Trivedi RH, Wilson ME. Secondary intraocular lens implantation following infantile cataract surgery: intraoperative indications, postoperative outcomes. Eye (Lond). 2016 Sep;30(9):1182-6. doi: 10.1038/eye.2016.131. Epub 2016 Jul 1.

  • Freedman SF, Beck AD, Nizam A, Vanderveen DK, Plager DA, Morrison DG, Drews-Botsch CD, Lambert SR; Infant Aphakia Treatment Study Group. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 Feb 1;139(2):165-173. doi: 10.1001/jamaophthalmol.2020.5664.

  • Shenoy BH, Mittal V, Gupta A, Sachdeva V, Kekunnaya R. Complications and visual outcomes after secondary intraocular lens implantation in children. Am J Ophthalmol. 2015 Apr;159(4):720-6. doi: 10.1016/j.ajo.2015.01.002. Epub 2015 Jan 9.

  • Zhao YE, Gong XH, Zhu XN, Li HM, Tu MJ, Coursey TG, Pflugfelder SC, Gu F, Chen D. Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: An ultrasound biomicroscopy study. PLoS One. 2017 Mar 16;12(3):e0172979. doi: 10.1371/journal.pone.0172979. eCollection 2017.

  • Whitman MC, Vanderveen DK. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014 Sep-Nov;29(5-6):414-20. doi: 10.3109/08820538.2014.959192.

  • Zou Y, Jin L, Qu B, Chen H, Zeng M, Li X, Liu X, Luo L, Liu Z, Liu Y. Safety and efficacy in pediatric secondary intraocular lens implantation, in-the-bag versus sulcus implantation: a multicenter, single-blinded randomized controlled trial. Trials. 2023 Jun 9;24(1):388. doi: 10.1186/s13063-023-07411-z.

Study Officials

  • Yizhi Liu, PhD

    Zhongshan Ophthalmic center, Guangzhou, People's Republic of China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhenzhen Liu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2021

First Posted

November 30, 2021

Study Start

December 14, 2021

Primary Completion

July 30, 2023

Study Completion (Estimated)

July 30, 2033

Last Updated

January 11, 2022

Record last verified: 2022-01

Locations